Bibliografisk note

Funding Information:
Potential competing interest: C.S. has served as speaker and advisory board member for MSD. L.E.K. has received fees for speaking and/or consultancy from Pfizer, AbbVie, Amgen, Forward Pharma, UCB, Gilead, Biogen, BMS, MSD, Novartis, Eli Lilly, and Janssen and research grants from UCB, Novartis, Pfizer, Eli Lilly, Biogen, AbbVie, and Janssen Pharmaceuticals. J.B. has been a consultant and/or advisory board fees and/or research grants from AbbVie, Pfizer, MSD, Takeda, Janssen, and Gilead.